Physician

Lingmin He, M.D.

According to 2025 Medicare claims, Lingmin He, M.D. (NPI: 1730405184) practices ophthalmology in the San Jose-Sunnyvale-Santa Clara, CA market, with the plurality of this provider's patient population coming from Santa Clara, CA. This provider's primary affiliated billing organization is RETINAL DIAGNOSTIC CENTER A MEDICAL CORPORATION (NPI: 1518030568; TIN: 942711267) and primary practice location at 95065-1579.

He's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 916 traditional Medicare patients, billed 82,545 HCPCS/CPT codes, and received $2,764,572 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 206 prescription claims across 91 beneficiaries totaling $18,500 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 32 records totaling $1,144. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $24,334 to $2,764,572. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $18,805 and ending at $18,500. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	126	184	$24,334
2016	159	506	$50,227
2017	252	1,726	$206,146
2018	395	3,287	$457,712
2019	504	4,800	$672,016
2020	381	4,237	$739,658
2021	590	6,177	$1,119,752
2022	533	6,374	$875,767
2023	909	35,547	$2,101,406
2024	916	82,545	$2,764,572

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	106	286	$18,805
2016	111	305	$15,117
2017	43	100	$5,526
2018	58	145	$10,502
2019	60	165	$14,938
2020	61	126	$9,376
2021	67	157	$9,378
2022	56	138	$11,869
2023	95	232	$18,913
2024	91	206	$18,500

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
67028	Injection of drug into eye	339	1,477	$102
92014	Established patient complete exam of visual system	736	1,109	$101
92012	Established patient problem focused exam of visual system	346	628	$79
92134	Imaging of retina	883	2,397	$35
J2777	Injection, faricimab-svoa, 0.1 mg	261	60,960	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	70	2,841	$3,194
Ketorolac Tromethamine	Ketorolac Tromethamine	20	666	$570
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	18	1,428	$257
Brimonidine Tartrate	Brimonidine Tartrate	22	1,015	$118
Latanoprost	Latanoprost	15	460	$50

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	32	$1,144	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Lingmin He, M.D.?

Tedicare shows public-source Medicare data for Lingmin He, M.D. (NPI 1730405184), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Lingmin He, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Lingmin He, M.D.?

Lingmin He, M.D. is linked to RETINAL DIAGNOSTIC CENTER A MEDICAL CORPORATION (billing NPI 1518030568) in the available physician profile data.

Does Lingmin He, M.D. have Open Payments data?

Lingmin He, M.D. has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.